Innovation, centralization, and growth. Coronary artery bypass graft surgery in Manitoba
- PMID: 2786119
Innovation, centralization, and growth. Coronary artery bypass graft surgery in Manitoba
Abstract
Innovation and diffusion of new surgical procedures are limited in Manitoba, Canada by restrictions on which hospitals are allowed to perform particular surgical programs. Programs centralizing performance of certain operations in a few hospitals have the potential for controlling costs and quality of care but may limit access for individuals living in other areas. Such issues are highlighted in this analysis of coronary artery bypass graft surgery in Manitoba. Patterns of growth and access are first examined; then regional variations in rates of bypass surgery are compared with rates for coronary angiography and valve surgery. Physician reluctance to refer patients to Winnipeg appears to be responsible for the lower rates of these procedures in Western Manitoba. The implications for studies of centralization/regionalization of medical services, physician decision-making, and diffusion of technology are explored.
Similar articles
-
Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.Crit Care Med. 2007 May;35(5):1296-301. doi: 10.1097/01.CCM.0000262403.08546.A2. Crit Care Med. 2007. PMID: 17414091 Clinical Trial.
-
Safety of elective--including "high risk"--percutaneous coronary interventions without on-site cardiac surgery.Am Heart J. 2004 Oct;148(4):676-83. doi: 10.1016/j.ahj.2004.03.040. Am Heart J. 2004. PMID: 15459600
-
Regional variation in angiography, coronary artery bypass surgery, and percutaneous transluminal coronary angioplasty in Manitoba, 1987 to 1992: the funnel effect.Med Care. 1998 Jul;36(7):1022-32. doi: 10.1097/00005650-199807000-00009. Med Care. 1998. PMID: 9674620
-
A case study of hospital closure and centralization of coronary revascularization procedures.CMAJ. 2001 May 15;164(10):1431-5. CMAJ. 2001. PMID: 11387915 Free PMC article.
-
Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.J Thorac Cardiovasc Surg. 2006 Feb;131(2):352-6. doi: 10.1016/j.jtcvs.2005.10.011. J Thorac Cardiovasc Surg. 2006. PMID: 16434264 Clinical Trial.
Cited by
-
Coronary revascularisation: why do rates vary geographically in the UK?J Epidemiol Community Health. 1995 Aug;49(4):408-12. doi: 10.1136/jech.49.4.408. J Epidemiol Community Health. 1995. PMID: 7650465 Free PMC article.
-
Regionalized delivery and variable utilization of coronary artery bypass grafting in Ontario from 1981 to 1991.CMAJ. 1994 Sep 1;151(5):575-80. CMAJ. 1994. PMID: 8069802 Free PMC article.
-
Volume of clinical activity in hospitals and healthcare outcomes, costs, and patient access.Qual Health Care. 1997 Jun;6(2):109-14. doi: 10.1136/qshc.6.2.109. Qual Health Care. 1997. PMID: 10173253 Free PMC article. Review. No abstract available.
-
Coronary artery bypass grafting in Canada: What is its rate of use? Which rate is right?CMAJ. 1992 Mar 15;146(6):851-9. CMAJ. 1992. PMID: 1544075 Free PMC article.
-
Coronary artery bypass grafting in Canada: national and provincial mortality trends, 1992-1995.CMAJ. 1998 Jul 14;159(1):25-31. CMAJ. 1998. PMID: 9679483 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical